Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$28.33 USD
+0.23 (0.82%)
Updated Jul 18, 2024 04:00 PM ET
After-Market: $28.34 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.95 | 1.41% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This reflects a positive earnings surprise of 2.08%. Look out for RPRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.95 per share, reflecting a year-over-year increase of 11.76%.
Earnings History
Price & Consensus
Zacks News for RPRX
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services